Your browser doesn't support javascript.
loading
Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results.
Wykoff, Charles C; Hershberger, Vrinda; Eichenbaum, David; Henry, Erin; Younis, Husam S; Chandra, Priya; Yuan, Nancy; Solloway, Mark; DePaoli, Alex.
Affiliation
  • Wykoff CC; Retina Consultants Texas, Retina Consultants of America, Houston, Texas, USA; Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas, USA. Electronic address: charleswykoff@gmail.com.
  • Hershberger V; Florida Eye Associates, Melbourne, Florida, USA.
  • Eichenbaum D; Retina Vitreous Associates of Florida, St. Petersburg, University of South Florida, Tampa, Florida, USA; Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • Henry E; NGM Biopharmaceuticals, Inc, South San Francisco, California, USA.
  • Younis HS; NGM Biopharmaceuticals, Inc, South San Francisco, California, USA.
  • Chandra P; NGM Biopharmaceuticals, Inc, South San Francisco, California, USA.
  • Yuan N; NGM Biopharmaceuticals, Inc, South San Francisco, California, USA.
  • Solloway M; NGM Biopharmaceuticals, Inc, South San Francisco, California, USA.
  • DePaoli A; NGM Biopharmaceuticals, Inc, South San Francisco, California, USA.
Am J Ophthalmol ; 235: 131-142, 2022 03.
Article in En | MEDLINE | ID: mdl-34509438
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Choroidal Neovascularization / Geographic Atrophy / Macular Degeneration Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Am J Ophthalmol Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Choroidal Neovascularization / Geographic Atrophy / Macular Degeneration Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Am J Ophthalmol Year: 2022 Type: Article